Christopher M Starr - Net Worth and Insider Trading
Christopher M Starr Net Worth
The estimated net worth of Christopher M Starr is at least $31 Million dollars as of 2024-05-05. Christopher M Starr is the SVP, Chief Scientific Officer of Biomarin Pharmaceutical Inc and owns about 295,176 shares of Biomarin Pharmaceutical Inc (BMRN) stock worth over $24 Million. Christopher M Starr is also the Director of Raptor Pharmaceutical Corp and owns about 701,044 shares of Raptor Pharmaceutical Corp (RPTP) stock worth over $6 Million. Details can be seen in Christopher M Starr's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Christopher M Starr has not made any transactions after 2015-03-23 and currently still holds the listed stock(s).
Transaction Summary of Christopher M Starr
Christopher M Starr Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Christopher M Starr owns 3 companies in total, including Monopar Therapeutics Inc (MNPR) , Raptor Pharmaceutical Corp (RPTP) , and Biomarin Pharmaceutical Inc (BMRN) .
Click here to see the complete history of Christopher M Starr’s form 4 insider trades.
Insider Ownership Summary of Christopher M Starr
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| MNPR | Monopar Therapeutics Inc | 2022-12-31 | director |
| RPTP | Raptor Pharmaceutical Corp | 2016-10-24 | director |
| BMRN | Biomarin Pharmaceutical Inc | 2005-12-01 | Sr. VP & Scientific Operations |
Christopher M Starr Latest Holdings Summary
Christopher M Starr currently owns a total of 2 stocks. Among these stocks, Christopher M Starr owns 295,176 shares of Biomarin Pharmaceutical Inc (BMRN) as of December 1, 2005, with a value of $24 Million and a weighting of 79.41%. Christopher M Starr also owns 701,044 shares of Raptor Pharmaceutical Corp (RPTP) as of March 23, 2015, with a value of $6 Million and a weighting of 20.59%.
Latest Holdings of Christopher M Starr
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| BMRN | Biomarin Pharmaceutical Inc | 2005-12-01 | 295,176 | 82.44 | 24,334,309 |
| RPTP | Raptor Pharmaceutical Corp | 2015-03-23 | 701,044 | 9.00 | 6,309,396 |
Holding Weightings of Christopher M Starr
Christopher M Starr Form 4 Trading Tracker
According to the SEC Form 4 filings, Christopher M Starr has made a total of 0 transactions in Biomarin Pharmaceutical Inc (BMRN) over the past 5 years. The most-recent trade in Biomarin Pharmaceutical Inc is the sale of 10,571 shares on December 1, 2005, which brought Christopher M Starr around $105,710.
According to the SEC Form 4 filings, Christopher M Starr has made a total of 0 transactions in Raptor Pharmaceutical Corp (RPTP) over the past 5 years. The most-recent trade in Raptor Pharmaceutical Corp is the sale of 20,033 shares on March 23, 2015, which brought Christopher M Starr around $232,783.
Insider Trading History of Christopher M Starr
- 1
Christopher M Starr Trading Performance
Christopher M Starr Ownership Network
Christopher M Starr Owned Company Details
What does Monopar Therapeutics Inc do?
Who are the key executives at Monopar Therapeutics Inc?
Christopher M Starr is the director of Monopar Therapeutics Inc. Other key executives at Monopar Therapeutics Inc include Chief Financial Officer Kim R Tsuchimoto , director & Chief Executive Officer Chandler Robinson , and other: Acting Chief Medical Officer Patrice Rioux .
Monopar Therapeutics Inc (MNPR) Insider Trades Summary
Over the past 18 months, Christopher M Starr made no insider transaction in Monopar Therapeutics Inc (MNPR). Other recent insider transactions involving Monopar Therapeutics Inc (MNPR) include a net purchase of 16,053 shares made by Andrew Cittadine ,
In summary, during the past 3 months, insiders sold 0 shares of Monopar Therapeutics Inc (MNPR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Monopar Therapeutics Inc (MNPR) were sold and 16,053 shares were bought by its insiders, resulting in a net purchase of 16,053 shares.
Monopar Therapeutics Inc (MNPR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Monopar Therapeutics Inc Insider Transactions
Christopher M Starr Mailing Address
Above is the net worth, insider trading, and ownership report for Christopher M Starr. You might contact Christopher M Starr via mailing address: C/o Monopar Therapeutics Inc, 1000 Skokie Blvd., Suite 350, Wilmette Il 60091.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
